622 CHAPTER 15
the brain mechanisms underlying them, including PTSD, depression, stroke,
spinal cord injuries, and ADHD, along with many others (Adeyemo et al., 2012;
Benito et al., 2012; Boggio, Rocha, et al., 2009; Cristancho et al., 2013; Helfrich
et al., 2012; Nitsche et al., 2009).
Another technique highlighted in Chapter Two is deep brain stimulation
(DBS). And while rTMS and tDCS are noninvasive, DBS is not and is used when
other approaches have failed. DBS is being evaluated as a treatment modality
for both depression and OCD (Denys et al., 2010; Holtzheimer et al., 2012), with
some evidence that DBS may also improve some neuropsychological functions
in depressed individuals (Moreines et al., 2014). Exciting research is investigat-
ing the use of DBS for individuals with chronic anorexia nervosa who have not
responded well to other treatments, with initial results suggesting some indi-
viduals have improved body mass index (BMI), mood, and anxiety symptoms
after DBS treatment (Lipsman et al., 2013). Pilot studies and initial investigations
are also examining the potential use of DBS in chronic obesity (Val-Laillet et al.,
2015; Whiting et al., 2013).
Deep brain stimulation (DBS) is an invasive procedure, and
sometimes used when all other treatment options have
failed. It involves the implantation of a pulse generator, a
device that will send electric stimulation to specific areas
of the brain.
Biomedical Therapies
psychosurgery
electroconvulsive
therapy
antipsychotic drugs: treat psychotic symptoms such as hallucinations, delusions,
and bizarre behavior; include the typical antipsychotics, atypical antipsychotics,
and partial dopamine agonists; work by blocking certain dopamine receptors
in the brain; long-term use has variety of risks, both behavioral and cognitive
antianxiety drugs: address anxiety and related disorders; include the minor
tranquilizers (benzodiazepines) that have a sedative effect—also have potential for
addiction and abuse; antidepressant drugs also used to treat anxiety disorders
mood-stabilizing drugs: address the manic episodes associated with bipolar disorder;
most common is lithium; may also include anticonvulsants and antidepressants
antidepressant drugs: are used to treat symptoms of depression and include
monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, and selective
serotonin reuptake inhibitors (SSRIs)
still used to treat severe depression and a few other disorders that
have not responded to other forms of treatment
involves the application of an electric shock and resulting seizure that
appears to normalize the balance of neurotransmitters within the brain
traditional side effects (extreme memory loss, broken bones) have been minimized
by lower levels of current and the use of both muscle relaxers and anesthesia
emerging
technologies
deep brain stimulation (DBS) for depression and OCD
used only as a last resort, involves cutting into the brain to remove or destroy brain
tissues associated with symptoms of a mental disorder
prefrontal lobotomies were widely used in the mid-1900s up until the development
of antipsychotic drugs
at present, bilateral anterior cingulotomy (involves selective areas of cingulate gyrus)
is used, primarily for obsessive-compulsive disorder; has also been used with depression
and bipolar disorder
repetitive transcranial magnetic stimulation (rTMS)
transcranial direct current stimulation (tDCS)
psychopharmacology
the use of drugs to control
or relieve the symptoms of
a psychological disorder;
may be used alone or in
combination with other
therapies (see Table 13.3)
being evaluated
as treatment options
for PTSD and depression,
and other disorders
Concept Map L.O. 15.10, 15.11, 15.12
Interactive
Reset